ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,32
0,52%
S&P 500
5.487,03
0,25%
Dow Jones
38.834,86
0,15%
Euro vs US Dollar
1,0718
-0,27%
Bitcoin
65.660,54
1,07%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Integra LifeSciences Holdings Corporation (IART)

  7. Integra LifeSciences Holdings Corporation (IART) News

IART Integra LifeSciences Holdings Corporation

29,00
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Integra LifeSciences Holdings Corporation IART NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 29,00 10:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
29,00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.6.202400:09PRNUSKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500;..
30.5.202422:40EDGAR2Form SD - Specialized disclosure report
24.5.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.5.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:38EDGAR2Form 8-K - Current report
13.5.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.5.202422:30GLOBEIntegra LifeSciences to Present at the 2024 Bank of America..
06.5.202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202412:15EDGAR2Form 8-K - Current report
06.5.202412:00GLOBEIntegra LifeSciences Reports First Quarter 2024 Financial..
30.4.202422:20GLOBEIntegra LifeSciences to Spotlight CereLink® Intracranial..
18.4.202423:24GLOBEIntegra LifeSciences to Reschedule the First Quarter 2024..
01.4.202422:15GLOBEIntegra LifeSciences Completes the Acquisition of Acclarent,..
11.3.202413:30GLOBEIntegra LifeSciences Launches MicroMatrix® Flex to Provide..
08.3.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:53EDGAR2Form 144 - Report of proposed sale of securities
28.2.202412:15EDGAR2Form 8-K - Current report
28.2.202412:10EDGAR2Form 8-K - Current report
28.2.202412:00GLOBEIntegra LifeSciences Reports Fourth Quarter and Full-Year..
27.2.202423:15EDGAR2Form 8-K/A - Current report: [Amend]
22.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202421:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202423:49EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07.2.202415:15GLOBEIntegra LifeSciences to Host Fourth Quarter and Full Year..
19.1.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:30GLOBEIntegra LifeSciences to Present at the 42nd Annual J.P...
20.12.202322:57EDGAR2Form 8-K - Current report
13.12.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202322:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
13.12.202322:31EDGAR2Form 8-K - Current report
13.12.202313:03DJNIntegra LifeSciences to Buy Acclarent From Johnson & Johnson
13.12.202312:30EDGAR2Form 8-K - Current report
13.12.202312:15GLOBEIntegra LifeSciences Announces Definitive Agreement to..
12.12.202318:00GLOBEIntegra LifeSciences Appoints Jeff Graves, Ph.D., to Board..
07.11.202319:54PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
03.11.202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202303:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
31.10.202310:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25.10.202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25.10.202312:15EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
IART
Integra LifeSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten